Koyama, Satoshi https://orcid.org/0000-0002-9286-0360
Liu, Xiaoxi https://orcid.org/0000-0002-1933-8613
Koike, Yoshinao https://orcid.org/0000-0002-5431-5572
Hikino, Keiko https://orcid.org/0000-0002-4852-2401
Koido, Masaru https://orcid.org/0000-0002-0348-0666
Li, Wei https://orcid.org/0009-0003-1419-9209
Akaki, Kotaro
Tomizuka, Kohei
Ito, Shuji
Otomo, Nao
Suetsugu, Hiroyuki
Yoshino, Soichiro
Akiyama, Masato
Saito, Kohei
Ishikawa, Yuki https://orcid.org/0000-0002-6514-8239
Benner, Christian
Natarajan, Pradeep https://orcid.org/0000-0001-8402-7435
Ellinor, Patrick T. https://orcid.org/0000-0002-2067-0533
Mushiroda, Taisei
Horikoshi, Momoko https://orcid.org/0000-0002-7103-2267
Ikeda, Masashi https://orcid.org/0000-0001-6237-2449
Iwata, Nakao https://orcid.org/0000-0003-3189-6076
Matsuda, Koichi https://orcid.org/0000-0001-7292-2686
,
Matsuda, Koichi
Niida, Shumpei
Ozaki, Kouichi https://orcid.org/0000-0003-0028-1570
Momozawa, Yukihide https://orcid.org/0000-0001-5638-3504
Ikegawa, Shiro https://orcid.org/0000-0003-0316-2147
Takeuchi, Osamu https://orcid.org/0000-0002-1260-6232
Ito, Kaoru https://orcid.org/0000-0003-1843-773X
Terao, Chikashi https://orcid.org/0000-0002-6452-4095
Funding for this research was provided by:
Japan Agency for Medical Research and Development (21kk0305013, 21tm0424220, 21ck0106642, 18km0605001, 21ae0121030)
MEXT | Japan Society for the Promotion of Science (20H00462, 22H03207, 18H05278)
the Medical Research Support Project of the Shizuoka Prefectural Hospital Organization
Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowships
Article History
Received: 17 May 2023
Accepted: 14 August 2024
First Online: 3 October 2024
Competing interests
: P.N. reports research grants from Allelica, Amgen, Apple, Boston Scientific, Genentech/Roche and Novartis; personal fees from Allelica, Apple, AstraZeneca, Blackstone Life Sciences, Creative Education Concepts, CRISPR Therapeutics, Eli Lilly & Co, Foresite Labs, Genentech/Roche, GV, HeartFlow, Magnet Biomedicine, Merck and Novartis; and scientific advisory board membership of Esperion Therapeutics, Preciseli and TenSixteen Bio. He is scientific cofounder of TenSixteen Bio; holds equity in MyOme, Preciseli and TenSixteen Bio; and reports spousal employment at Vertex Pharmaceuticals, all unrelated to the present work. The other authors declare no competing interests.